We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
WEC Energy
WEC
$35.4B
| $33.1M | 0.08% |
328,508
+59,100
| +22% | +$5.99M |
|
|
AAC
277
DELISTED
Ares Acquisition Corporation
AAC
| $32.9M | 0.08% |
3,350,000
| – | – |
|
278
Amalgamated Financial
AMAL
$1.49B
| $32.9M | 0.08% |
1,663,837
-80,285
| -5% | -$1.55M |
|
279
Kinder Morgan
KMI
$69.6B
| $32.9M | 0.08% |
1,961,854
+1,569,600
| +400% | +$29.4M |
|
280
Adient
ADNT
$1.65B
| $32.6M | 0.07% |
1,100,000
+400,000
| +57% | +$13.4M |
|
281
Alkermes
ALKS
$8.25B
| $32.5M | 0.07% |
+1,090,000
| New | +$31.3M |
|
282
Simon Property Group
SPG
$73.6B
| $32.5M | 0.07% |
341,963
-1,200
| -0.3% | -$138K |
|
|
PPL
283
PPL Corp
PPL
$26.5B
| $32.3M | 0.07% |
1,191,400
-1,892,500
| -61% | -$54.3M |
|
284
ResMed
RMD
$31.9B
| $31.9M | 0.07% |
152,384
-300
| -0.2% | -$63.9K |
|
285
Republic Services
RSG
$64B
| $31.7M | 0.07% |
241,942
+19,100
| +9% | +$2.51M |
|
286
International Flavors & Fragrances
IFF
$20.7B
| $31.6M | 0.07% |
265,400
-516,681
| -66% | -$64.6M |
|
287
HP
HPQ
$25.6B
| $31.6M | 0.07% |
962,536
+111,400
| +13% | +$4.09M |
|
288
GFL Environmental
GFL
$15.1B
| $31.4M | 0.07% |
1,215,435
-310,000
| -20% | -$9.19M |
|
|
RETA
289
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $31.1M | 0.07% |
+1,025,000
| New | +$30.6M |
|
290
Penumbra
PEN
$12.8B
| $31.1M | 0.07% |
250,000
+110,000
| +79% | +$17.5M |
|
291
Biogen
BIIB
$30.4B
| $31.1M | 0.07% |
152,499
+134,100
| +729% | +$27.4M |
|
292
Kroger
KR
$35.2B
| $31.1M | 0.07% |
657,106
+313,001
| +91% | +$16.7M |
|
|
PRPC
293
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $31M | 0.07% |
3,150,000
| – | – |
|
294
Roper Technologies
ROP
$38.7B
| $30.7M | 0.07% |
+77,801
| New | +$33.8M |
|
295
Ecolab
ECL
$78.9B
| $30.6M | 0.07% |
198,825
-61,500
| -24% | -$10.2M |
|
296
DexCom
DXCM
$32.7B
| $30.5M | 0.07% |
408,800
+4,100
| +1% | +$374K |
|
297
Eversource Energy
ES
$27.2B
| $30.3M | 0.07% |
359,134
+100
| +0% | +$8.88K |
|
298
Williams Companies
WMB
$87.7B
| $30.2M | 0.07% |
968,499
-300,300
| -24% | -$10.4M |
|
299
Axsome Therapeutics
AXSM
$10.9B
| $30M | 0.07% |
783,662
+133,662
| +21% | +$4.23M |
|
300
Armstrong World Industries
AWI
$7.64B
| $30M | 0.07% |
400,000
-250,000
| -38% | -$21.1M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.